ESSA Pharma Inc. - stock earnings
EPIX Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -6.0 million USD | ? USD |
2023Q3 | -5.5 million USD | ? USD |
2023Q2 | -7.3 million USD | ? USD |
2023Q1 | -7.1 million USD | ? USD |
2022Q4 | -6.7 million USD | ? USD |
2022Q3 | -6.3 million USD | ? USD |
2022Q2 | -8.8 million USD | ? USD |
2022Q1 | -10.8 million USD | ? USD |
2021Q4 | -9.1 million USD | ? USD |
2021Q3 | -8.6 million USD | ? USD |
2021Q2 | -8.8 million USD | ? USD |
2021Q1 | -13.0 million USD | ? USD |
2020Q4 | -6.5 million USD | ? USD |
2020Q3 | -4.5 million USD | ? USD |
2020Q2 | -4.9 million USD | ? USD |
2020Q1 | -9.4 million USD | ? USD |
2019Q4 | -4.6 million USD | ? USD |
2019Q3 | -1.0 million USD | ? USD |
2019Q2 | -3.3 million USD | ? USD |
2019Q1 | -3.4 million USD | ? USD |
2018Q4 | -2.7 million USD | ? USD |
2018Q3 | -2.3 million USD | ? USD |
2018Q2 | -2.9 million USD | ? USD |
2018Q1 | -4.4 million USD | ? USD |
2017Q4 | -2.1 million USD | ? USD |
2017Q3 | -1.9 million USD | ? USD |
2017Q2 | 3.6 million USD | ? USD |
2017Q1 | -7.6 million USD | ? USD |
2016Q4 | 1.5 million USD | ? USD |
2016Q3 | -4.2 million USD | 217 USD |
2016Q2 | -3.9 million USD | ? USD |
2016Q1 | -1.1 million USD | ? USD |
2015Q4 | -4.0 million USD | ? USD |
2015Q3 | 1.3 million USD | ? USD |
2015Q2 | -5.1 million USD | ? USD |
2015Q1 | -3.4 million USD | ? USD |
2014Q4 | -1.3 million USD | ? USD |
2014Q3 | -468700 USD | ? USD |
2014Q2 | -981421 USD | ? USD |
2014Q1 | -137939 USD | ? USD |
2013Q4 | -231350 USD | ? USD |
EPIX Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -26.6 million USD | ? USD |
2022 | -35.1 million USD | ? USD |
2021 | -36.8 million USD | ? USD |
2020 | -23.4 million USD | ? USD |
2019 | -10.4 million USD | ? USD |
2018 | -11.6 million USD | ? USD |
2017 | -4.5 million USD | ? USD |
2016 | -13.1 million USD | 217 USD |
2015 | -8.6 million USD | ? USD |
2014 | -1.8 million USD | ? USD |
EPIX
Price: $6.96
52 week price:
Earnings Per Share: -0.59 USD
P/E Ratio: -16.33
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 44601
Ebitda: -1.8 millionMarket Capitalization: 319.8 million